George A. Eldridge is SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE). They have made 2 open-market trades across 1 company since 2022, most recently 2024-06-14.
CIK 0001413006
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AVTE | 20,022 | $54K |
Shares reported on the most recent Form 4, priced at the 2024-06-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVTE | SELL · 10b5-1 | 2024-06-14 | 2024-06-14 | $25.03 | $375K | -30.7% | -21.2% | -22.0% |
| AVTE | SELL · 10b5-1 | 2024-04-10 | 2024-04-12 | $26.81 | $382K | -16.3% | -24.5% | -92.6% |
| AVTE | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $31.23 | $780K | -14.6% | -31.5% | -94.5% |
| AVTE | SELL · 10b5-1 | 2024-03-12 | 2024-03-14 | $25.04 | $204K | +5.1% | +3.6% | -5.7% |
| AVTE | SELL · 10b5-1 | 2024-03-07 | 2024-03-11 | $25.06 | $736K | +5.4% | +9.5% | -11.4% |
| AVTE | SELL | 2022-12-09 | 2022-12-13 | $27.61 | $479K | +7.1% | -9.9% | -15.6% |
| AVTE | SELL | 2022-12-07 | 2022-12-09 | $21.89 | $1.0M | +2.3% | -3.6% | -13.3% |
| AVTE | SELL · 10b5-1 | 2022-11-30 | 2022-12-02 | $19.06 | $2K | +43.6% | +50.9% | +30.8% |
| AVTE | SELL · 10b5-1 | 2022-11-23 | 2022-11-28 | $19.07 | $24K | +51.8% | +70.4% | +52.7% |
| AVTE | SELL · 10b5-1 | 2022-11-18 | 2022-11-22 | $19.43 | $20K | -6.5% | +36.7% | +40.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.